EML4 and non-small cell lung carcinoma: Similar results were observed in a cohort of 200 patients with NSCLC, in which RT-PCR yielded the highest EML4–ALK positivity at 12.5% versus IHC and FISH analysis, which had positivity rates of 6.7% and 4.5%, respectively (63).